Informex and CMS Pharma Present Inaugural CEO Summit of Pharma Manufacturing
By Informex, PRNETuesday, December 7, 2010
First annual CEO Summit will provide forum for senior industry executives to discuss business strategies and trends in Custom Manufacturing of pharmaceutical ingredients
PRINCETON, New Jersey and INGELHEIM, Germany, December 8, 2010 - Informex, the leading meeting place for buyers and sellers of high-value
chemistry for a broad range of applications, and CMS Pharma, the trusted M&A
and corporate strategy advisor for the Custom Manufacturing industry, today
announced the first annual CEO Summit of Pharma Manufacturing, to be held in
Charlotte, North Carolina, on February 6th 2011, one day prior to the opening
of the annual flagship InformexUSA event. The invitation only summit will
bring together the leading CEOs and Business Unit Executives in the Contract
Manufacturing and Contract Research sectors to discuss business strategies
and industry trends, while providing a high level networking forum.
"By holding the CEO Summit a day before the exhibition begins, we are
able to provide an additional, value adding resource for our VIP attendees at
InformexUSA and aim to make this a must-attend annual networking event for
high level executives within the Pharma Contract Services sector," commented
Jennifer Jessup, Global Brand Director of Informex. "In order to encourage
continued communication on the topics addressed during the summit, in
conjunction with CMS Pharma, we will also be providing guests with an
exclusive blog where they can conduct further conversations and network
throughout the year."
CMS Pharma will deliver high quality and original content for the half
day event and will facilitate the discussion among senior industry figures.
The summit will review what has happened in the past several years as well as
future projections for the Contract Manufacturing industry.
Discussion topics will focus on top industry trends, fundamental shifts
in pharma Custom Manufacturing and will examine how CEOs can leverage these
to the benefit of their respective companies. Specific topics will include:
- Market trends over the past five years and the rise of India as API manufacturing hub - Pipeline deals: manufacturing site acquisitions and their side effects - Current outlook: a business model under stress - Likely market development scenario by 2015 - Path forward for the custom manufacturing industry
"The need to develop a platform to exchange at the highest levels on
long-term industry trends led us to deign the CEO Summit. The partnership to
produce it with Informex came about very organically. We are both drawing on
our strengths for the event," noted Andrew Badrot, Founder & CEO, CMS Pharma.
"Our deep understanding of the industry coupled with our experience will
enable us to provide a program full of high quality information and pertinent
analysis transforming the event into a great place to network and learn, but
also a true 'think tank' of great minds."
All content and discussions within the summit will be subject to an
anti-trust agreement in order to support open discussion and freedom of
thought, as well as to encourage participation of all guests in attendance.
To participate in the summit, guests must be a CEO or Pharma Business Segment
head and their company must either be an attendee or exhibitor at
InformexUSA.
To find out more information about the summit or to request an invitation
please visit: www.informex.com
UBM Live (UBMLive) is a wholly owned subsidiary of United Business Media
plc (LSE: UBM) a leading provider of business information services to the
maritime, travel, fashion, technology, healthcare, media, and property
industries. UBM offers services in trade shows, online, news distribution,
and publishing to customers across the globe. Its brands are represented in
more than 30 countries and are organized into specialist teams that serve
their business communities helping them excel in their market by working
effectively and efficiently. For more information, go to
www.ubmlive.com.
About Informex: Organized by UBM Live, Informex is the leading meeting
place for buyers and sellers of high-value chemistry for a broad range of
applications. As the premier, must-attend, event for the chemical industry
for the past 27 years, Informex is a marketplace for networking and doing
business in the fine, custom and specialty chemical manufacturing industry.
The show traces its origin to a group of members from the Society of Chemical
Manufacturers and Associates (SOCMA) who were looking for an annual place to
meet and do business. Each year the event brings together an international
mix of more than 4,000 fine and specialty chemicals professionals and 500
exhibitors for the all encompassing, 4 day event.
CMS Pharma is the trusted M&A and corporate strategy advisor delivering
specialized solutions for the custom manufacturing industry, including
buy-side and sell-side advisory services, fairness opinions, valuations and
business strategies designed to address an increasingly commoditized business
landscape.
CMS Pharma also provides consulting services and best practices to
pharmaceutical companies looking to divest their chemical production assets
and outsource major portions of their product portfolio.
Jennifer Jessup, Global Brand Director, UBM Live, +1-609-759-4707, jennifer.jessup at ubm.com; Andrew Badrot, Founder & CEO, CMS Pharma GmbH & Co. KG, +49-6132-436-8410, andrew.badrot at cms-pharma.com; Richard Kerns, +44(0)161-728-5880, richard at impress-pr.com, or Erin Hatzi, +1-503-928-7870, erin at impress-pr.com, both of Impress Public Relations
Tags: December 8, Germany, Informex, new jersey, New Jersey And Ingelheim, Princeton, Western Europe